Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -7.03% and Operating profit at -140.86% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 5.21% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -7.03% and Operating profit at -140.86% over the last 5 years
3
Flat results in Mar 26
4
With ROE of 1.23%, it has a expensive valuation with a 2.14 Price to Book Value
Stock DNA
Chemicals & Petrochemicals
CNY 5,347 Million (Mid Cap)
176.00
NA
0.00%
0.46
1.23%
1.95
Revenue and Profits:
Net Sales:
1,218 Million
(Quarterly Results - Jun 2026)
Net Profit:
64 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.94%
0%
-7.94%
6 Months
-15.63%
0%
-15.63%
1 Year
10.42%
0%
10.42%
2 Years
82.17%
0%
82.17%
3 Years
17.05%
0%
17.05%
4 Years
-12.27%
0%
-12.27%
5 Years
-68.54%
0%
-68.54%
Liaoning Oxiranchem, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-7.03%
EBIT Growth (5y)
-140.86%
EBIT to Interest (avg)
-0.81
Debt to EBITDA (avg)
7.06
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.90
Tax Ratio
23.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.81%
ROE (avg)
5.21%
Valuation key factors
Factor
Value
P/E Ratio
176
Industry P/E
Price to Book Value
2.17
EV to EBIT
-1177.51
EV to EBITDA
55.25
EV to Capital Employed
1.80
EV to Sales
1.66
PEG Ratio
1.19
Dividend Yield
NA
ROCE (Latest)
-0.15%
ROE (Latest)
1.23%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
1,218.20
1,067.00
14.17%
Operating Profit (PBDIT) excl Other Income
76.90
41.40
85.75%
Interest
14.60
16.30
-10.43%
Exceptional Items
-0.10
0.00
Consolidate Net Profit
63.60
7.10
795.77%
Operating Profit Margin (Excl OI)
23.50%
-6.50%
3.00%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 14.17% vs 0.01% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 795.77% vs -59.89% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
4,222.50
4,266.20
-1.02%
Operating Profit (PBDIT) excl Other Income
168.20
84.40
99.29%
Interest
59.00
51.70
14.12%
Exceptional Items
-6.80
-12.70
46.46%
Consolidate Net Profit
27.20
-148.30
118.34%
Operating Profit Margin (Excl OI)
-3.50%
-33.30%
2.98%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -1.02% vs 12.55% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 118.34% vs 50.73% in Dec 2024
About Liaoning Oxiranchem, Inc. 
Liaoning Oxiranchem, Inc.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






